2017-12-05

Tenure Track Position Advertisement

Hi All,

Rutgers, The State University of New Jersey, is seeking an assistant or associate professor level tenure track faculty member for their Master’s in Applied Psychology Program (MAP) housed in The Graduate School of Applied and Professional Psychology (GSAPP) and the Center of Alcohol Studies. This faculty member will develop the alcohol and drug use curriculum for the new Master’s Program concentration in alcohol and substance use disorders, and provide support to the Director of the MAP program as well as the Director of the Center of Alcohol Studies.  The full advertisement is attached to this email and the link to apply is here: http://jobs.rutgers.edu/postings/53207.

Cheers,

Matt

Matthew T. Weaver, Ph.D.

Assistant Professor                                                

Department of Psychology

Hafenmaier College of Humanities, Arts, and Social Sciences

Mercyhurst University

Phone: 814.824.2733

Email: mweaver@mercyhurst.edu

 

P Please consider the environment before printing this correspondence.

 

************************

Statement of Confidentiality:

The contents of this e-mail message and any attachments are confidential and are intended solely for addressee. The information may also be legally privileged. This transmission is sent in trust, for the sole purpose of delivery to the intended recipient. If are not the intended addressee or you have received this transmission in error, any use, reproduction or dissemination of this transmission is strictly prohibited. If you are not the intended recipient, please immediately notify the sender by reply e-mail or phone and delete this message and its attachments, if any.

 

 

[DIV28ANNOUNCE] Division 28 newsletter

Good afternoon APA Division 28,

 

Attached is the November issue of the division newsletter.  I hope everyone has a wonderful holiday season!

 

Regards,

Erin McClure 

 

 

----------------------

Erin A. McClure, Ph.D.

Assistant Professor

Addiction Sciences Division

Medical University of South Carolina

67 President St, MSC 861

Charleston, SC  29425

Phone: 843-792-7192

Fax: 843-792-8206

 

 

Like us on Facebook and Follow us on Twitter!

 

 

 

2017-12-02

[#DIV28SUPER] DEADLINE EXTENDED: 2018 APA Convention in San Francisco (DUE MONDAY)

Friends and Colleagues –

 

Because of technical problems with the APA Convention website (http://www.apa.org/convention/proposals.aspx), the deadline for divisional proposals has been extended until Monday.  If you encounter problems, or if you need additional time, then please reach out to me (masmith@davidson.edu) or to our program chair, Dr. Michael Wesley (michael.wesley@uky.edu), and we will be as accommodating as possible.

 

We are looking forward to an exciting 2018 Convention.

 

Mark

 

Mark Smith, PhD

President-Elect

Division 28 (Psychopharmacology and Substance Abuse)

American Psychological Association

 

2018 APA Convention in San Francisco

 

Call for Proposals: http://www.apa.org/convention/index.aspx

Submission Portal: https://my.apa.org/apa/idm/login.seam

 

We are excited to encourage any and all basic science and clinical researchers to submit abstracts for the 126th annual American Psychological Association convention. This year's convention will be held in beautiful San Francisco, California on August 9-12, 2018.

 

The 2018 Division 28 program will provide multiple networking opportunities and will highlight several hot-topic areas, including the opioid crisis and cannabis legalization, and clinical and research tools, like non-invasive brain stimulation and data crowdsourcing. We especially welcome submissions dealing with topics related to substance abuse in diverse populations, but all submissions related to psychopharmacology and substance abuse are welcome. We hope to see submissions featuring the work of students, early career investigators and established investigators.

 

More information about the convention is available at: http://www.apa.org/convention/index.aspx. Abstracts for individual submissions are due December 1st (by 5pm EST) and can be submitted online here: https://my.apa.org/apa/idm/login.seam.

 

 

2017-12-01

[#DIV28SUPER] Experimental and Clinical Psychopharmacology

Dear Colleagues-
Please consider submitting your work for publication in Experimental and Clinical Psychopharmacology. The journal accepts brief communications (no more than 3000 words, excluding references; no more than 2 total figures or tables), case reports (no more than 2000 words; only 1 figure or table) and brief reviews (no more than 5000 words, excluding references), in addition to original research reports (no word limit, but should typically be 4-8000 words, excluding references) and full reviews (no word limit). The journal scope is appended below.
Please feel free to contact me directly at william.stoops@uky.edu if you have questions about submitting to Experimental and Clinical Psychopharmacology.
Thank you,
Bill Stoops.

Experimental and Clinical Psychopharmacology® publishes advances in translational and interdisciplinary research on psychopharmacology, broadly defined, and/or substance abuse.

The scope of research in these areas continues to expand and to benefit from collaborations across a broad range of disciplines, including behavioral science, biochemistry, brain imaging, genetics, medicine, neuroendocrinology, neuroscience, and pharmacology.

The overall goal of Experimental and Clinical Psychopharmacology is to provide a forum for high-quality, innovative preclinical and clinical research that advances our understanding of the behavioral and biological determinants of the effects of centrally acting drugs.

The journal publishes original reports and brief communications on the development and evaluation of pharmacotherapies for a range of mental health diagnoses, the influence of genetics and hormones on responses to psychoactive drugs, the pharmacological management of pain, and brain imaging studies of the neural correlates of psychoactive drug effects.

Rigorous preclinical and human laboratory studies, as well as controlled clinical trials of novel interventions, relevant to psychopharmacology and/or substance abuse, are particularly encouraged. The journal recommends that all submissions consider relevant biological variables (e.g., age, animal strain, sex) that may influence outcomes in study design and statistical analyses.

When appropriate (e.g., to provide initial clinical documentation of an emerging issue or topic in psychopharmacology and/or substance abuse), the journal will publish case reports. Case reports are expected to be thoughtful and thorough with attention paid to underlying etiology, behavioral, clinical, and laboratory findings. Any hypotheses should be supported by data and extant literature.

The journal will also include integrative reviews, both full and brief, of advances in research on psychopharmacology and/or substance abuse. Full reviews should provide a broad perspective on a particular area of research or trace the development of critical concepts and experimental approaches. Brief reviews should provide a scholarly perspective on a circumscribed topic or a novel area that has a relatively small number of relevant research studies to consider. It is recommended that authors contact the editor prior to review preparation regarding suitability for the journal.

Each year, the journal will recognize individuals who are recipients of awards from APA Division 28 (Psychopharmacology and Substance Abuse). Awardees will be invited to submit a full or brief review paper based on their award-winning research contributions.

 

               
---------------------------------------------------------------------------------
William W. Stoops, Ph.D.
email: william.stoops@uky.edu
phone: (859) 257-5383
facsimile: (859) 257-7684


Professor
University of Kentucky College of Medicine
Department of Behavioral Science
Department of Psychiatry
Center on Drug and Alcohol Research
University of Kentucky College of Arts and Sciences
Department of Psychology

Director
Regulatory Knowledge and Support Core
Component Lead
Research Methods
University of Kentucky Center for Clinical and Translational Science

STATEMENT OF CONFIDENTIALITY
The contents of this e-mail message and any attachments are confidential and are intended solely for the addressee. The information may also be legally privileged. This transmission is sent in trust, for the sole purpose of delivery to the intended recipient. If you have received this transmission in error, any use, reproduction or dissemination of this transmission is strictly prohibited. If you are not the intended recipient, please immediately notify the sender by reply e-mail or at (859) 257-5383 and delete this message and its attachments, if any.

2017-11-27

[#DIV28SUPER] FINAL CALL: 2018 APA Convention in San Francisco (PROPOSALS DUE THIS FRIDAY)

FINAL Call for Abstracts and Symposia: 2018 APA Convention in San Francisco (DUE THIS FRIDAY)


Call for Proposals: http://www.apa.org/convention/index.aspx

Submission Portal: https://my.apa.org/apa/idm/login.seam

Divisional Deadline: December 1st (by 5pm EST) THIS FRIDAY!

 

We are excited to encourage any and all basic science and clinical researchers to submit abstracts for the 126th annual American Psychological Association convention. This year's convention will be held in beautiful San Francisco, California on August 9-12, 2018.

 

We need your help in making this a strong and breakout convention that highlights the latest and greatest in clinical and basic science research. Make plans now to drink great coffee and dodge bicycles on the way to see terrific posters and presentations. Take pleasure in knowing that someone is tech-ing out on a cable car trying to get to YOUR AWESOME WORK.  Together we can make this happen!

 

The 2018 Division 28 program will provide multiple networking opportunities and will highlight several hot-topic areas, including the opioid crisis and cannabis legalization, and clinical and research tools, like non-invasive brain stimulation and data crowdsourcing. We especially welcome submissions dealing with topics related to substance abuse in diverse populations, but all submissions related to psychopharmacology and substance abuse are welcome. We hope to see submissions featuring the work of students, early career investigators and established investigators.

 

More information about the convention is available at: http://www.apa.org/convention/index.aspx. Abstracts for individual submissions are due December 1st (by 5pm EST) and can be submitted online here: https://my.apa.org/apa/idm/login.seam.

 

Please email me (michael.wesley@uky.edu) with questions and be on the lookout for announcements about craft beer and our awesome 2018 convention plans.

 

Michael Wesley, Ph.D.

 

2017-11-25

[#DIV28SUPER] Post-docs at Univ So California

We anticipate 2-3 post-doc openings in our NCI T32 program at USC starting in summer/fall 2018.  This is a great opportunity for anyone interested in any area of tobacco or alcohol use or any other cancer risk behavior.

Please feel free to distribute to colleagues.

Best,

Adam

POSTDOCTORAL FELLOWSHIPS

The Keck School of Medicine of the University of Southern California seeks candidates for one- to three-year research fellowships (pending final funding decisions). Fellowship positions provide mentored training in research as well as protected time to participate in publishing, grant writing, and other career development activities. Fellows will have the opportunity to work with an interdisciplinary group of faculty who conduct research on the determinants, epidemiology, and intervention/prevention of behavioral influences on cancer risk: (a) tobacco product, alcohol, and drug use; (b) obesity, diet, physical activity, and sedentary behavior; (c) sexually-transmitted infections related to cancer (e.g., HPV infection); and (d) cancer survivorship. We seek candidates with backgrounds and interests that complement existing strengths in: (1) health disparities and social/environmental determinants of health; (2) psychological influences on health behavior, (3) behavioral and social science methodologies (e.g., longitudinal data analysis, ecological momentary assessment, social network analysis, qualitative research, and human biobehavioral laboratory paradigms), (4) developmental processes and youth/young-adult health behavior; and (5) psychoneuroimmunology.

The fellowship program is administered by the Division of Health Behavior Research within the Department of Preventive Medicine and provides an annual salary (based upon year doctorate received), health insurance, tuition, and conference travel support. This multidisciplinary department of behavioral scientists, epidemiologists, environmental health scientists, and biostatisticians has a long history of conducting innovative externally-funded research and currently holds active research programs on tobacco products, obesity, cancer survivorship, and other public health issues. Many faculty members are also members of the USC/Norris Cancer Center, an NCI-Designated Comprehensive Cancer Center with strong research programs in cancer control and epidemiology. 

More information about can be found at ipr.usc.edu and uscnorriscancer.usc.edu. Qualified individuals must have completed a PhD, MD or equivalent, and must be a US citizen or have permanent resident status. Women, minorities, and candidates from other underrepresented groups are especially encouraged to apply. USC is an Equal Opportunity/Affirmative Action employer. 

Send curriculum vitae and statement of interest to: Marny Barovich, barovich@usc.edu; or call 323-442-8299 for more information.
--
Adam Leventhal, Ph.D.
Director, USC Health, Emotion, & Addiction Laboratory
Associate Professor of Preventive Medicine and Psychology
USC Norris Comprehensive Cancer Center
Keck School of Medicine
University of Southern California
2250 Alcazar St., CSC 271
Los Angeles, CA 90033
Phone: 323-442-8222

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28

2017-11-17

[#DIV28SUPER] NINDS seeks a Director to lead its extramural Division of Neuroscience.

Director, Division of Neuroscience National Institute of Neurological Disorders and Stroke (NINDS):   NINDS seeks a Director to lead its extramural Division of Neuroscience.  The Director of the Division of Neuroscience will be responsible for planning and directing a program of extramural and collaborative research in neuroscience, guiding NINDS’s largest research portfolio and charting the future of a vibrant, growing neuroscience research community https://www.ninds.nih.gov/.  The Division of Neuroscience has a flat organizational structure and includes 29 Program Directors and 17 Analysts assigned to 6specific scientific clusters including Neurogenetics, Channels, Synapses and Circuits, Systems, Cognitive Neuroscience, Repair and Plasticity, Neurodegeneration, and Neural Environment http://intranet.ninds.nih.gov/employee/policies_procedures/extramural/manual/D_Pre_Award_Procedures/Cluster_PD_Interests.pdf.

 

The Director will also be responsible for coordinating NINDS’s neuroscience collaborations across multiple NIH Institutes and Centers and with other Federal and private partners.  The Director will be a primary advisor to the NINDS Director and will report to the NINDS Director. The Director of the Division of Neuroscience will lead a group of approximately 60 professional staff.  The research portfolio of the Division of Neuroscience includes an annual budget of over $1 billion dollars in grants and over $30 million in R&D contracts.  Salary will be commensurate with experience. The position will be filled under a Title 42(f) excepted service appointment and a full package of federal benefits will be provided.  If you are ready for an exciting leadership opportunity, please see the link to the detailed Vacancy Announcement under Jobs at NINDS https://www.ninds.nih.gov/About-NINDS/Jobs-NINDS

 

 

This is being sent on behalf of NINDS a sister institute at NIH by NIDA.  The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email - You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov   301-435-1309